On May 11, 2020 SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, reported that management will present a corporate overview at the UBS Virtual Global Healthcare Conference on May 18, 2020 at 10:50am EST (Press release, SQZ Biotech, MAY 11, 2020, View Source [SID1234557529]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be available through the UBS Virtual Global Healthcare Conference webcast system linked here. Armon Sharei, PhD, chief executive officer, and Teri Loxam, chief financial officer, will also be hosting one-on-one meetings with investors through the virtual system.